Stay updated on ISB 830 Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the ISB 830 Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the ISB 830 Efficacy in Atopic Dermatitis Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the study page, indicating a minor update; no study data, endpoints, or eligibility criteria appear to be affected; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.3.4 is now shown in the revision history, replacing v3.3.3; no substantive study content or criteria were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now includes an expanded Locations section listing trial sites across the United States, Canada, and several European regions, and the revision tag was updated to v3.3.3.SummaryDifference2%

- Check74 days agoChange DetectedThe header now displays Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedOne site-wide notice about government funding and potential delays has been removed from the page. The removed notice warned that information might not be up to date and that NIH operations could be affected.SummaryDifference0.2%

- Check102 days agoChange DetectedNo additions or deletions are visible between the old and new screenshots; the page content and layout appear unchanged.SummaryDifference0.2%

Stay in the know with updates to ISB 830 Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ISB 830 Efficacy in Atopic Dermatitis Clinical Trial page.